Questions discussed in this category
As immune checkpoint inhibitors have expanded into the neoadjuvant breast cancer setting, severe and unexpected autoimmune toxicities may cause delays...
If so, what dose-fractionation do you utilize? What other factors do you take into consideration?
The patient is on a dose of 22 mg of methotrexate weekly for severe rheumatoid arthritis.
If you would discontinue the methotrexate, how long would y...
The patient has notable lip lesions from her discoid lupus erythematosus
How does a diagnosis of active RA inform your treatment approach for patients with breast cancer, if at all?
In a patient with early stage breast cancer that would otherwise require radiation, would you recommend treatment if the patient has active skin lupus...
Do you always stick with a conventional fracionation, or in some cases, are you comfortable hypofractionating? Do you ever use a wait and see approach...
Do you put more weight on specific CVDs such as scleroderma as contraindications for any RT?
Do you have any concern for increased toxicity when you treat a patient with radiation therapy who has an autoimmune disorder? (hypofractiationation v...
237841716490981533517216144201395412155321333591247790656
Papers discussed in this category
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997-07
Brachytherapy, 2011
Brachytherapy, 2011
JAMA Netw Open, 2021 Feb 01
Lancet Oncol., 2013-10-01
Arthritis care & research, 2018-10
Breast Care (Basel), 2019 Aug 16
Arthritis and rheumatism, 2013-07
Lancet, 2021 May 07
Arthritis care & research, 2023 Nov 28
JAMA network open, 2024 May 01
Arthritis care & research, 2024 Oct 16